Form D To Observe: Panther Therapeutics $500000 Fundraising. Laura Indolfi Released Nov 7 SEC form

Health Care Panther Therapeutics, Inc. - Laura Indolfi

Panther Therapeutics Financing

Panther Therapeutics, Inc., Corporation just submitted form D because of $500,000 debt financing. This is a new filing. Panther Therapeutics was able to finance itself with $35,000 so far. That is 7.00% of the fundraising. The total offering amount was $500,000. This form was filed on 2016-11-07. The reason for the financing was: unspecified. The fundraising still has about $465,000 more and is not closed yet. We have to wait more to see if the offering will be fully taken.

Panther Therapeutics is based in Massachusetts. The company’s business is Other Health Care. The form was submitted by Laura Indolfi President. The company was incorporated in 2014. The filler’s address is: C/O Labcentral, 700 Main Street, Cambridge, Ma, Massachusetts, 02139. Laura Indolfi is the related person in the form and it has address: C/O Labcentral, 700 Main Street, Cambridge, Ma, Massachusetts, 02139. Link to Panther Therapeutics Filing: 000164404516000006.

Analysis of Panther Therapeutics Offering

On average, companies in the Other Health Care sector, sell 68.60% of the total offering amount. Panther Therapeutics sold 7.00% of the offering. The financing is still open. The average fundraising amount for companies in the Other Health Care industry is $1.16 million. The offering was 96.98% smaller than the average of $1.16 million. Of course this should not be taken as negative. Startups get financed for different needs and reasons. The minimum investment for this offering is set at $0. If you know more about the reasons for the fundraising, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Panther Therapeutics Also

The Form D signed by Laura Indolfi might help Panther Therapeutics, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment